Waystar Explores Potential Sale
Healthcare software provider Waystar is exploring a potential sale just two years after its stock market listing. The company has hired Evercore and Barclays to advise on the early-stage process.
Xurve View
Insights:
Xurve View

Healthcare software provider WAYSTAR HOLDING CORP is exploring options including a potential sale valued at about $5.2 billion. The process comes just two years after its stock market listing in the United States. The move could return the firm to private hands amid a broader tech sector selloff.





